586 related articles for article (PubMed ID: 21906967)
1. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.
Messer JC; Terrell JD; Herman MP; Ng CK; Scherr DS; Scoll B; Boorjian SA; Uzzo RG; Wille M; Eggener SE; Lucas SM; Lotan Y; Shariat SF; Raman JD
Urol Oncol; 2013 Aug; 31(6):904-8. PubMed ID: 21906967
[TBL] [Abstract][Full Text] [Related]
2. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
[TBL] [Abstract][Full Text] [Related]
3. Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?
Ng CK; Shariat SF; Lucas SM; Bagrodia A; Lotan Y; Scherr DS; Raman JD
Urol Oncol; 2011; 29(1):27-32. PubMed ID: 19117771
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
5. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
Grasso M; Fishman AI; Cohen J; Alexander B
BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China.
Chen XP; Xiong GY; Li XS; Matin SF; Garcia M; Fang D; Wang TY; Yu W; Gong K; Song Y; He ZS; He Q; Zhou LQ
BJU Int; 2013 Nov; 112(7):917-24. PubMed ID: 23905945
[TBL] [Abstract][Full Text] [Related]
7. Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma.
Ito Y; Kikuchi E; Tanaka N; Miyajima A; Mikami S; Jinzaki M; Oya M
J Urol; 2011 May; 185(5):1621-6. PubMed ID: 21419429
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
[TBL] [Abstract][Full Text] [Related]
9. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
Messer J; Shariat SF; Brien JC; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Steinberg G; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
BJU Int; 2011 Sep; 108(5):701-5. PubMed ID: 21320275
[TBL] [Abstract][Full Text] [Related]
10. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.
Brien JC; Shariat SF; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
J Urol; 2010 Jul; 184(1):69-73. PubMed ID: 20478585
[TBL] [Abstract][Full Text] [Related]
11. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
[TBL] [Abstract][Full Text] [Related]
12. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; MartÃnez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
13. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
Wheat JC; Weizer AZ; Wolf JS; Lotan Y; Remzi M; Margulis V; Wood CG; Montorsi F; Roscigno M; Kikuchi E; Zigeuner R; Langner C; Bolenz C; Koppie TM; Raman JD; Fernández M; Karakiewizc P; Capitanio U; Bensalah K; Patard JJ; Shariat SF
Urol Oncol; 2012; 30(3):252-8. PubMed ID: 20451416
[TBL] [Abstract][Full Text] [Related]
14. Factors impacting survival in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy.
Mouracade P; Velten M; Gigante M; Alenda O; Ploussard G; Obadia F; Timsit MO; Mejean A
Can J Urol; 2012 Feb; 19(1):6105-10. PubMed ID: 22316512
[TBL] [Abstract][Full Text] [Related]
15. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
Chromecki TF; Cha EK; Fajkovic H; Margulis V; Novara G; Scherr DS; Lotan Y; Raman JD; Kassouf W; Bensalah K; Weizer A; Kikuchi E; Roscigno M; Remzi M; Matsumoto K; Walton TJ; Pycha A; Ficarra V; Karakiewicz PI; Zigeuner R; Pummer K; Shariat SF
Eur Urol; 2012 Feb; 61(2):245-53. PubMed ID: 21975249
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
[TBL] [Abstract][Full Text] [Related]
17. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.
Favaretto RL; Shariat SF; Savage C; Godoy G; Chade DC; Kaag M; Bochner BH; Coleman J; Dalbagni G
BJU Int; 2012 Jan; 109(1):77-82. PubMed ID: 21631698
[TBL] [Abstract][Full Text] [Related]
18. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
[TBL] [Abstract][Full Text] [Related]
19. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
